Ignite Creation Date:
2025-12-25 @ 2:37 AM
Ignite Modification Date:
2026-06-14 @ 5:08 PM
Study NCT ID:
NCT06211634
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-12-24
First Post:
2024-01-09
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 1/2 Study to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of HMB-001 in Glanzmann Thrombasthenia
Sponsor:
Hemab ApS
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
HMB-001-CL101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None